Chemed CHE Deferred Tax Liabilities, Regulatory Assets
Deferred Tax Liabilities, Regulatory Assets at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesRegulatoryAssets.
The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's deferred tax liabilities, regulatory assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's deferred tax liabilities, regulatory assets?
- Chemed (CHE) reported deferred tax liabilities, regulatory assets of $4.69M in Q4 2025.
- How has Chemed's deferred tax liabilities, regulatory assets changed year-over-year?
- Chemed's deferred tax liabilities, regulatory assets increased by 10.5% year-over-year, from $4.24M to $4.69M.
- What is the long-term trend for Chemed's deferred tax liabilities, regulatory assets?
- Over 5 years (2020 to 2025), Chemed's deferred tax liabilities, regulatory assets has grown at a 3.6% compound annual growth rate (CAGR), from $3.92M to $4.69M.
- What does deferred tax liabilities, regulatory assets mean?
- This represents deferred tax liabilities associated with regulatory assets that are expected to be recovered from customers in future periods. It captures the tax impact of timing differences between regulatory accounting and tax law. This metric is essential for assessing the future cash flow implications of regulatory rate-making processes.